RNA
USDAvidity Biosciences Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$69.780
High
$69.870
Low
$69.760
Volume
7.06M
Company Fundamentals
Market Cap
10.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
5.20M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
TD Cowen Downgrades Avidity Biosciences to Hold, Lowers Price Target to $74
TD Cowen analyst Ritu Baral downgrades Avidity Biosciences from Buy to Hold and lowers the price target from $78 to $74.
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders
The Ademi Firm is investigating Avidity (Nasdaq: RNA) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Chardan Capital Downgrades Avidity Biosciences to Neutral, Lowers Price Target to $72
Chardan Capital analyst Keay Nakae downgrades Avidity Biosciences from Buy to Neutral and lowers the price target from $75 to $72.
RBC Capital Downgrades Avidity Biosciences to Sector Perform, Raises Price Target to $72
RBC Capital analyst Luca Issi downgrades Avidity Biosciences from Outperform to Sector Perform and raises the price target from $61 to $72.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avidity Biosciences, Inc. (NASDAQ: RNA)
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
Avidity Biosciences to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.
Related Stocks
PMCB
PharmaCyte Biotech Inc.
DKL
Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
ZVIA
Zevia PBC
KTN
Structured Products Corp 8.205% CorTS 8.205% Corporate Backed Trust Securities (CorTS)
FTHY
First Trust High Yield Opportunities 2027 Term Fund
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.